Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Armata Pharmaceuticals (ARMP) Other Non Operating Income (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Other Non Operating Income for 6 consecutive years, with $2.0 million as the latest value for Q4 2018.

  • Quarterly Other Non Operating Income rose 27971.43% to $2.0 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2018, down 17.93% year-over-year, with the annual reading at -$121.0 million for FY2025, 485.35% down from the prior year.
  • Other Non Operating Income hit $2.0 million in Q4 2018 for Armata Pharmaceuticals, up from -$105000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $26.4 million in Q3 2014 to a low of -$12.2 million in Q1 2015.
  • Historically, Other Non Operating Income has averaged $2.7 million across 5 years, with a median of $834000.0 in 2015.
  • Biggest YoY gain for Other Non Operating Income was 27971.43% in 2018; the steepest drop was 2725.0% in 2018.
  • Year by year, Other Non Operating Income stood at $1.9 million in 2014, then tumbled by 67.1% to $636000.0 in 2015, then soared by 184.28% to $1.8 million in 2016, then crashed by 99.61% to $7000.0 in 2017, then skyrocketed by 27971.43% to $2.0 million in 2018.
  • Business Quant data shows Other Non Operating Income for ARMP at $2.0 million in Q4 2018, -$105000.0 in Q3 2018, and -$101000.0 in Q2 2018.